Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: Preliminary results of consecutive seven cases

Clinical Transplantation

Volumn 27, Issue 2, 2013, Pages 227-231

  Soejima, Yuji ^a   Muto, Jyun ^a   Matono, Rumi ^a   Ninomiya, Mizuki ^a   Ikeda, Tetsuo ^a   Yoshizumi, Tomoharu ^a   Uchiyama, Hideaki ^a   Ikegami, Toru ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Living donor liver transplantation; Plasma exchange; Rejection; Rituximab

Indexed keywords

AMPHOTERICIN; AMPICILLIN; CEFOTAXIME; GANCICLOVIR; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; SULBACTAM; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER SURVIVAL; CHOLESTASIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOTHERAPY; INTERNAL JUGULAR VEIN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NEPHRITIS; OPERATION DURATION; PLASMAPHERESIS; PORTAL VEIN THROMBOSIS; PORTOCAVAL SHUNT; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLENECTOMY; SURVIVAL; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLASMA EXCHANGE; SPLENECTOMY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84876071961     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12060     Document Type: Article

References (21)

1. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990: 336: 519.
2. Farges O, Kalil AN, Samuel D et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995: 59: 1124.
3. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008: 47: 143.
4. Troisi R, Noens L, Montalti R et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006: 12: 1412.
5. Hanto DW, Fecteu AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003: 9: 22.
6. Saliba F, Ichaï P, Azoulay D et al. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns. Therap Apher Dial 2010: 14: 116.
7. Urbani L, Mazzoni A, Bianco I et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apheresis 2008: 23: 55.
8. Goralczyk AD, Obed A, Schnitzbauer A et al. Adult living donor liver transplantation with ABO-incompatible grafts: a German single center experience. J Transplant 2009; 2009: 759581. Epub 2010 February 3.
9. Tanabe M, Shimazu M, Wakabayashi G et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002: 73: 1959.
10. Kozaki K, Egawa H, Kasahara M et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Therap Apher Dial 2005: 9: 285.
11. Yoshizawa A, Sakamoto K, Ogawa M et al. New protocol of immunosuppression for liver transplantation across ABO-barrier: the use of rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 2005: 37: 1718.
12. Soejima Y, Shimada M, Suehiro T et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl 2003: 9: 581.
13. Uchiyama H, Ikegami T, Soejima Y et al. Use of recipient's left hepatic artery for artery reconstruction in right lobe living donor liver transplantation with duct-to-duct anastomosis. Transplantation 2010: 89: 1016.
14. Soejima Y, Shimada M, Suehiro T et al. Feasibility of duct-to-duct biliary reconstruction in left lobe adult living donor liver transplantation. Transplantation 2003: 75: 557.
15. Ikegami T, Toshima T, Takeishi K et al. Bloodless splenectomy during liver transplantation for terminal liver disease with portal hypertension. J Am Coll Surg 2009: 208: e1.
16. Ikegami T, Taketomi A, Soejima Y et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO-incompatible living donor liver transplantation. Transplantation 2009: 88: 303.
17. Haga H, Egawa H, Fujimoto Y et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006: 12: 457.
18. Egawa H, Ohmori K, Haga H et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 2007: 13: 579.
19. Browning JL. B-cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 2006: 5: 564.
20. Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living donor liver transplantation. Clin Transplant 2007: 21: 24.
21. Soejima Y, Taketomi A, Yoshizumi T et al. Feasibility of left-lobe living donor liver transplantation between adults: an 8-years, single center experience of 107 cases. Am J Transplant 2006: 6: 1004.